一种用于新冠肺炎心脏中巨噬细胞介导炎症的免疫心脏模型。
An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts.
作者信息
Yang Liuliu, Han Yuling, Jaffré Fabrice, Nilsson-Payant Benjamin E, Bram Yaron, Wang Pengfei, Zhu Jiajun, Zhang Tuo, Redmond David, Houghton Sean, Uhl Skyler, Borczuk Alain, Huang Yaoxing, Richardson Chanel, Chandar Vasuretha, Acklin Joshua A, Lim Jean K, Chen Zhengming, Xiang Jenny, Ho David D, tenOever Benjamin R, Schwartz Robert E, Evans Todd, Chen Shuibing
机构信息
Department of Surgery (L.Y., Y. Han, F.J., J.Z., T.E., S.C.), Weill Cornell Medicine, New York, NY.
Department of Microbiology (B.E.N.-P., S.U., J.K.L., B.R.t.), Icahn School of Medicine at Mount Sinai, New York, NY.
出版信息
Circ Res. 2021 Jun 25;129(1):33-46. doi: 10.1161/CIRCRESAHA.121.319060. Epub 2021 Apr 15.
Abstract
[Figure: see text].
摘要
[图：见正文]。
相似文献
1
An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts.一种用于新冠肺炎心脏中巨噬细胞介导炎症的免疫心脏模型。
Circ Res. 2021 Jun 25;129(1):33-46. doi: 10.1161/CIRCRESAHA.121.319060. Epub 2021 Apr 15.
2
Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts.来自人类心血管祖细胞的细胞外囊泡在梗死心脏中引发修复性免疫反应。
Cardiovasc Res. 2021 Jan 1;117(1):292-307. doi: 10.1093/cvr/cvaa028.
3
NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy.NFĸB 信号通过致心律失常性心肌病的临床前模型中的 CCR2+巨噬细胞驱动心肌损伤。
J Clin Invest. 2024 Apr 2;134(10):e172014. doi: 10.1172/JCI172014.
4
Sex differences in immunological responses to COVID-19: a cross-sectional analysis of a single-centre cohort.新型冠状病毒肺炎免疫反应中的性别差异：一项单中心队列的横断面分析
Br J Anaesth. 2021 Aug;127(2):e75-e78. doi: 10.1016/j.bja.2021.05.013. Epub 2021 May 27.
5
Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block.Ro60 相关的单链 RNA 通过 TLR 连接将炎症与胎儿心脏纤维化联系起来：自身免疫性相关心脏传导阻滞的新途径。
J Immunol. 2010 Feb 15;184(4):2148-55. doi: 10.4049/jimmunol.0902248. Epub 2010 Jan 20.
6
COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism.COVID-19 心肌炎：炎症浸润的定量分析及提出的发病机制。
Cardiovasc Pathol. 2021 Sep-Oct;54:107361. doi: 10.1016/j.carpath.2021.107361. Epub 2021 Jun 24.
7
Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart.病毒诱导的急性呼吸窘迫综合征通过在心脏中引发炎症反应引起心肌病。
Circulation. 2024 Jul 2;150(1):49-61. doi: 10.1161/CIRCULATIONAHA.123.066433. Epub 2024 Mar 20.
8
Cardiac pathology in COVID-19: a single center autopsy experience.COVID-19 患者的心脏病理学：一项单中心尸检研究。
Cardiovasc Pathol. 2021 Sep-Oct;54:107370. doi: 10.1016/j.carpath.2021.107370. Epub 2021 Jul 14.
9
Human Cardiac Mesenchymal Stem Cells Remodel in Disease and Can Regulate Arrhythmia Substrates.人心肌间充质干细胞在疾病中重塑，并可调节心律失常基质。
Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008740. doi: 10.1161/CIRCEP.120.008740. Epub 2020 Jul 29.
10
Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died.死于 SARS-CoV-2 感染和免疫介导性肌病的患者之间的关联。
JAMA Neurol. 2021 Aug 1;78(8):948-960. doi: 10.1001/jamaneurol.2021.2004.
引用本文的文献
1
Association between novel Immune-Inflammatory markers and hypertension patients with coronary heart disease: A Cross-Sectional study based on NHANES (2005-2016).新型免疫炎症标志物与高血压合并冠心病患者的关联：基于美国国家健康与营养检查调查（2005 - 2016）的横断面研究
BMC Cardiovasc Disord. 2025 Jul 4;25(1):467. doi: 10.1186/s12872-025-04906-2.
2
Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury.免疫调节：对抗SARS-CoV-2诱导的心肌损伤的关键。
Front Immunol. 2025 May 14;16:1561946. doi: 10.3389/fimmu.2025.1561946. eCollection 2025.
3
Organoids in virology.病毒学中的类器官
Npj Viruses. 2024 Feb 7;2(1):5. doi: 10.1038/s44298-024-00017-5.
4
Risk impact of SARS-CoV-2 coronavirus and spike protein on cardiac tissue: a comprehensive review.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）及其刺突蛋白对心脏组织的风险影响：一项综述
Physiol Res. 2024 Dec 31;73(S3):S655-S669. doi: 10.33549/physiolres.935476.
5
Lab-on-a-chip models of cardiac inflammation.心脏炎症的芯片实验室模型
Biomicrofluidics. 2024 Oct 29;18(5):051507. doi: 10.1063/5.0231735. eCollection 2024 Sep.
6
CCL2-mediated endothelial injury drives cardiac dysfunction in long COVID.CCL2 介导体内皮损伤导致长新冠心脏功能障碍。
Nat Cardiovasc Res. 2024 Oct;3(10):1249-1265. doi: 10.1038/s44161-024-00543-8. Epub 2024 Oct 14.
7
Unraveling the relevance of SARS-Cov-2 infection and ferroptosis within the heart of COVID-19 patients.揭示新型冠状病毒肺炎患者心脏中严重急性呼吸综合征冠状病毒2感染与铁死亡的相关性。
Heliyon. 2024 Aug 24;10(17):e36567. doi: 10.1016/j.heliyon.2024.e36567. eCollection 2024 Sep 15.
8
Human vascularized macrophage-islet organoids to model immune-mediated pancreatic β cell pyroptosis upon viral infection.人类血管化巨噬细胞-胰岛类器官模型模拟病毒感染时免疫介导的胰腺β细胞细胞焦亡。
Cell Stem Cell. 2024 Nov 7;31(11):1612-1629.e8. doi: 10.1016/j.stem.2024.08.007. Epub 2024 Sep 3.
9
Human Vascularized Macrophage-Islet Organoids to Model Immune-Mediated Pancreatic β cell Pyroptosis upon Viral Infection.用于模拟病毒感染后免疫介导的胰腺β细胞焦亡的人血管化巨噬细胞-胰岛类器官
bioRxiv. 2024 Aug 6:2024.08.05.606734. doi: 10.1101/2024.08.05.606734.
10
The emerging role of heart-on-a-chip systems in delineating mechanisms of SARS-CoV-2-induced cardiac dysfunction.芯片心脏系统在阐明SARS-CoV-2诱导的心脏功能障碍机制中的新作用。
Bioeng Transl Med. 2023 Aug 8;9(3):e10581. doi: 10.1002/btm2.10581. eCollection 2024 May.
本文引用的文献
1
Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection.人类肾脏是新型严重急性呼吸综合征冠状病毒 2 感染的靶器官。
Nat Commun. 2021 May 4;12(1):2506. doi: 10.1038/s41467-021-22781-1.
2
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.使用肺和结肠类器官鉴定 SARS-CoV-2 抑制剂。
Nature. 2021 Jan;589(7841):270-275. doi: 10.1038/s41586-020-2901-9. Epub 2020 Oct 28.
3
Two distinct immunopathological profiles in autopsy lungs of COVID-19.COVID-19 患者尸检肺组织中的两种不同免疫病理特征。
Nat Commun. 2020 Oct 8;11(1):5086. doi: 10.1038/s41467-020-18854-2.
4
Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study.COVID-19 相关心肌损伤的病理特征：一项多中心心血管病理学研究。
Eur Heart J. 2020 Oct 14;41(39):3827-3835. doi: 10.1093/eurheartj/ehaa664.
5
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.SARS-CoV-2 感染并诱导人心肌细胞产生细胞毒性作用。
Cardiovasc Res. 2020 Dec 1;116(14):2207-2215. doi: 10.1093/cvr/cvaa267.
6
Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection.人诱导多能干细胞衍生的心肌细胞易受新冠病毒感染。
Cell Rep Med. 2020 Jul 21;1(4):100052. doi: 10.1016/j.xcrm.2020.100052. Epub 2020 Jun 29.
7
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases.心脏感染与确诊 COVID-19 尸检病例中 SARS-CoV-2 的关联。
JAMA Cardiol. 2020 Nov 1;5(11):1281-1285. doi: 10.1001/jamacardio.2020.3551.
8
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids.基于人多能干细胞的平台，用于研究 SARS-CoV-2 嗜性和人类细胞及类器官中的病毒感染模型。
Cell Stem Cell. 2020 Jul 2;27(1):125-136.e7. doi: 10.1016/j.stem.2020.06.015. Epub 2020 Jun 19.
9
Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies.检测心肌活检中的病毒 SARS-CoV-2 基因组和组织病理学变化。
ESC Heart Fail. 2020 Oct;7(5):2440-2447. doi: 10.1002/ehf2.12805. Epub 2020 Jun 12.
10
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.意大利北部一系列 COVID-19 病例的肺脏尸检结果：一项两中心描述性研究。
Lancet Infect Dis. 2020 Oct;20(10):1135-1140. doi: 10.1016/S1473-3099(20)30434-5. Epub 2020 Jun 8.
Zotero 插件